A Phase 2A Trial of DT402 for Autism Spectrum Disorder
A Phase 2A Trial of DT402 for Autism Spectrum Disorder
Recruiting · NCT07303907 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2A Trial of DT402 for Autism Spectrum Disorder | atrial septal defect, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-09-02 | NCT07303907 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Definium Therapeutics US, Inc. | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Spectrum Neuroscience and Treatment Institute | New York | United States | 2 |